LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $226,000 | +12.4% | 1,658 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $201,000 | -57.8% | 1,658 | -64.6% | 0.00% | -75.0% |
| Q4 2016 | $476,000 | +25.3% | 4,680 | +25.6% | 0.00% | +33.3% |
| Q3 2016 | $380,000 | -25.3% | 3,726 | -12.7% | 0.00% | -25.0% |
| Q2 2016 | $509,000 | -21.0% | 4,270 | -28.9% | 0.00% | -33.3% |
| Q1 2016 | $644,000 | -2.3% | 6,009 | -1.1% | 0.01% | 0.0% |
| Q4 2015 | $659,000 | +89.9% | 6,075 | +49.9% | 0.01% | +50.0% |
| Q3 2015 | $347,000 | +69.3% | 4,054 | +99.8% | 0.00% | +100.0% |
| Q2 2015 | $205,000 | -23.2% | 2,029 | -41.4% | 0.00% | -33.3% |
| Q1 2015 | $267,000 | -21.5% | 3,464 | -45.7% | 0.00% | -25.0% |
| Q4 2014 | $340,000 | +10.0% | 6,383 | -3.0% | 0.00% | 0.0% |
| Q3 2014 | $309,000 | – | 6,583 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |